Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy

Front Immunol. 2022 Nov 7:13:1074864. doi: 10.3389/fimmu.2022.1074864. eCollection 2022.

Authors

Jianping Wu¹, Xiaona Wei¹, Jiajia Li¹, Yangang Gan¹, Rui Zhang¹, Qianqian Han¹, Peifen Liang¹, Yuchun Zeng¹, Qiongqiong Yang¹

Affiliation

¹ Department of Nephrology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.978315.].

Keywords: Biomarker; Exosome; IgA nephropathy; Renin-angiotensin system inhibitors; Treatment response.

Copyright © 2022 Wu, Wei, Li, Gan, Zhang, Han, Liang, Zeng and Yang.

Publication types

Published Erratum